RxDoctor Payments Data

Jason Garlie, MD

Cardiovascular Disease · Coon Rapids, MNNPI 1497913479

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $67,385 of the $74,808 with a category attached, or 90.1%. 13 manufacturers reported payments, led by Baxter Healthcare at 53.5% of the total. 2025 is the largest year on record at $34,591, 8.8 times the $3,928 reported in 2019. Among cardiovascular disease clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$74,808in general payments, 2019–2025

Across 146 payments — averaging $512.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Baxter Healthcare$40K
  • Abbott$27K
  • Medtronic$3K
  • Boston Scientific$3K
  • Cvrx, Inc.$1K
  • Biotronik Inc.$317
  • plus $240 from 7 others
$168,852in research payments, 2019–2025

Across 49 payments — averaging $3445.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$169K

What the payments were for

  • Consulting fees$67,38590%
  • Travel & lodging$1,6782%
  • Food & beverage$5,7458%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$74,808 in reported general payments places this provider in the 90th percentile of 451 cardiovascular disease providers in Minnesota.

See all cardiovascular disease providers in Minnesota

Medicare billing

Part B allowed, 2024
$141,388
Medicare patients
962
Services billed
2,387

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban129$169,584
XareltoRivaroxaban60$78,398
Metoprolol Succinate80$1,607
Flecainide Acetate46$1,239
SotalolSotalol Hcl46$1,047
Amiodarone Hcl39$819
Atorvastatin Calcium27$811
Propranolol Hcl13$390
Amlodipine Besylate21$349
Metoprolol Tartrate45$344
Diltiazem 24hr Er (Cd)Diltiazem Hcl20$339
Rosuvastatin Calcium26$310
Losartan Potassium11$292
Mupirocin31$231
Warfarin Sodium21$171

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Coon Rapids

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →